Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Liabilities
QFRTL385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
1,119,269.00
Year-over-Year Change
8.83%
Date Range
10/1/2000 - 1/1/2025
Summary
The Quarterly Financial Report (QFR) measures the total liabilities of U.S. pharmaceutical and medicine corporations. This metric provides insight into the financial health and debt levels of a crucial industry.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The QFR total liabilities trend tracks the aggregate debt, payables, and other financial obligations of corporations in the pharmaceuticals and medicines sector. It is a key indicator of the industry's financial position and can inform economic analysis and policy decisions.
Methodology
The data is collected through quarterly surveys of large U.S. corporations.
Historical Context
Policymakers and analysts use this metric to assess the financial stability and credit conditions in the pharmaceutical industry.
Key Facts
- The pharmaceutical industry is a major contributor to the U.S. economy.
- Total liabilities provide a snapshot of a company's financial obligations.
- Quarterly reporting allows for timely analysis of industry trends.
FAQs
Q: What does this economic trend measure?
A: The Quarterly Financial Report (QFR) total liabilities trend measures the aggregate debt, payables, and other financial obligations of U.S. pharmaceutical and medicine corporations.
Q: Why is this trend relevant for users or analysts?
A: This metric provides insight into the financial health and stability of the pharmaceutical industry, which is a critical sector for the U.S. economy.
Q: How is this data collected or calculated?
A: The data is collected through quarterly surveys of large U.S. corporations conducted by the U.S. Federal Reserve.
Q: How is this trend used in economic policy?
A: Policymakers and analysts use this metric to assess credit conditions and financial stability in the pharmaceutical industry, which can inform economic policy decisions.
Q: Are there update delays or limitations?
A: The QFR data is released on a quarterly basis, so there may be a short delay in the most recent information being available.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Computer and Electronic Products: Trade Accounts and Trade Notes Receivable (Less Allowance for Doubtful Accounts)
QFRD213COMUSNO
Quarterly Financial Report: U.S. Corporations: All Other Information: Cash Dividends Charged to Retained Earnings This Quarter
QFR120519USNO
Quarterly Financial Report: U.S. Corporations: Textile Mills and Textile Product Mills: All Other Current Assets
QFR215313USNO
Quarterly Financial Report: U.S. Corporations: Furniture and Related Products: Accumulated Depreciation, Depletion, and Amortization
QFR218337USNO
Quarterly Financial Report: U.S. Corporations: Computer Systems Design and Related Services: Long-Term Debt, Due in More Than 1 Year: Loans from Banks
QFR316545USNO
Quarterly Financial Report: U.S. Corporations: Computer and Electronic Products: Total Current Assets
QFRTCACOMUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Liabilities (QFRTL385USNO), retrieved from FRED.